1. Home
  2. ONTF vs PRLD Comparison

ONTF vs PRLD Comparison

Compare ONTF & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ON24 Inc.

ONTF

ON24 Inc.

HOLD

Current Price

$8.11

Market Cap

347.2M

Sector

Technology

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$3.95

Market Cap

312.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONTF
PRLD
Founded
1998
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
347.2M
312.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ONTF
PRLD
Price
$8.11
$3.95
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$8.10
$5.67
AVG Volume (30 Days)
986.7K
298.3K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
32.67
23.21
EPS
N/A
N/A
Revenue
$139,312,000.00
$12,140,000.00
Revenue This Year
N/A
$320.10
Revenue Next Year
$1.51
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
73.43
52 Week Low
$4.70
$0.75
52 Week High
$8.11
$5.54

Technical Indicators

Market Signals
Indicator
ONTF
PRLD
Relative Strength Index (RSI) 67.87 45.88
Support Level $7.84 $3.92
Resistance Level N/A $4.10
Average True Range (ATR) 0.02 0.31
MACD -0.01 -0.03
Stochastic Oscillator 88.89 46.49

Price Performance

Historical Comparison
ONTF
PRLD

About ONTF ON24 Inc.

ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others. Geographically, the company derives maximum revenue from United States, and also has its presence in EMEA and Other Countries.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: